Please login to the form below

Not currently logged in
Email:
Password:

Dr Desiree Luthman joins Verona Pharma

She takes up its vice president position

Desiree LuthmanUK-based clinical stage biopharma company Verona Pharma has appointed Dr Desiree Luthman as its vice president of regulatory affairs.

Luthman’s expertise lies in a series of roles leading regulatory affairs teams and strategies for pharmaceutical products spanning from early development to post-approval marketing.

She has also held various regulatory positions for global pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene and AstraZeneca.

Jan-Anders Karlsson, chief executive officer of Verona Pharma, said: “We welcome Desiree to our growing pharma team.

“She has an accomplished track record of working closely with the FDA and EMA on behalf of international healthcare companies to achieve key regulatory milestones.

“Her vast experience will be instrumental as we advance our regulatory plans in the US and Europe under her leadership in our effort to deliver important new therapies to patients with respiratory diseases.”

Prior to her new role in Verona Pharma, Luthman previously directed regulatory activities related to pulmonary disease at Sanofi and led its regulatory team through the FDA approval of dupilumab for atopic dermatitis in the US.

27th June 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics